Becton, Dickinson and Company

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

Becton Dickinson stock heads into the open after a modest loss

AI-generated analysis

πŸ“‰ Becton, Dickinson and Company (BDX) finished lower on September 11, 2026, posting a modest loss in a quiet trading session on the NYSE.

πŸ“Š Intraday share turnover for BDX reached a moderate level, reflecting subdued activity compared to busier days earlier in the month.

🏦 Institutional investor The Manufacturers Life Insurance Company recently reduced its stake in Becton, Dickinson and Company, indicating portfolio repositioning.

🎯 Analyst consensus maintains a 'hold' rating for BDX with an average target price modestly above the latest closing price.

πŸ“… Becton, Dickinson and Company has no major company-specific events scheduled within the immediate five-trading-day window ahead of the next session.

🌍 The stock's future performance is expected to be driven by broader US economic releases and general healthcare-sector news rather than specific corporate catalysts.

Risk Factors
  • Institutional investor The Manufacturers Life Insurance Company recently reduced its stake in Becton, Dickinson and Company, indicating some portfolio repositioning away from the stock.
  • Becton, Dickinson and Company closed lower on September 11, 2026, recording a modest loss as share prices eased in a relatively calm trading session.
Full Analysis
Becton, Dickinson and Company (BDX) closed lower on the New York Stock Exchange on September 11, 2026, recording a modest loss as share prices eased in a relatively calm trading session. The daily decline reflected a minor negative move against the prior close, with intraday activity remaining within a narrow band between the day's low and high. Trading volume for BDX was moderate, indicating subdued investor activity relative to busier sessions earlier in the month. The stock remained within its established 52-week range according to major US quote data providers, suggesting stability despite the short-term dip. Institutional ownership data indicates that The Manufacturers Life Insurance Company recently reduced its stake in Becton, Dickinson and Company, signaling some portfolio repositioning around the security. Analyst consensus currently rates the stock as a 'hold' with an average target price positioned modestly above the latest closing level. Looking ahead to the market open, BDX faces no major company-specific catalysts such as earnings releases or annual meetings within the immediate five-trading-day window. Consequently, the stock's performance will likely be influenced by broader US economic releases and general healthcare-sector news rather than specific corporate developments.